Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
USANA Health Sciences Inc(USNA)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for USNA
10/26/2026: USNA (1-star) is currently NOT-A-BUY. Pass it for now.
USANA Health Sciences is a global direct-selling company that focuses on premium, science-backed nutritional and personal care products. The company has a leading position in specific wellness segments and has historically delivered strong margins through in-house manufacturing. Its primary growth opportunity lies in leveraging digital transformation to support its associate base. However, the company faces notable risks, including intense competition from e-commerce, regional regulatory pressures, and a declining consumer appetite for the traditional direct-selling model. The stock may suit investors looking for exposure to the wellness sector, though they should monitor revenue stabilization in China and the company's success in adapting to evolving consumer shopping behaviors.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Weak fit | Current revenue trends indicate a period of stagnation rather than high-growth momentum. |
| Momentum investor | Weak fit | The stock lacks the positive price action required for momentum strategies. |
| Value investor | Mixed fit | While the company has a solid balance sheet and reasonable valuation metrics, growth catalysts remain elusive. |
| Dividend investor | Weak fit | USANA does not prioritize dividend payments, focusing instead on share buybacks. |
| Low-risk investor | Mixed fit | The company's strong balance sheet reduces financial risk, but market and business-model risks remain notable. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | The stock is susceptible to fluctuations based on consumer sentiment and international market performance. |
| Valuation risk | Medium | Market pricing reflects uncertainty regarding future growth prospects. |
| Competition risk (Direct-selling/Retail) | High | The company faces immense pressure from e-commerce and established retail brands. |
| Business quality | Medium / high | The company has historically maintained high margins, but its business model faces structural headwinds. |
| Dividend income | Low / none | The company does not provide a regular dividend stream to investors. |
| Execution risk | Medium / high | Successfully navigating international regulatory environments and associate recruitment is critical to performance. |
Price Behavior
Steep Decline
The stock price has dropped sharply with strong downward pressure.
Extreme Price Shocks
The stock has experienced exceptionally large and disruptive price movements during the period.
Analysis of Past Performance
Type Stock | Historic Profit -57.06% | Avg. Invested days 27 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/26/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 257.93M USD | Price to earnings Ratio - | 1Y Target Price 25 |
Price to earnings Ratio - | 1Y Target Price 25 | ||
Volume (30-day avg) 182.0K shares | Beta 0.68 | 52 Weeks Range 12.57 - 23.59 | Updated Date 10/25/2026 |
52 Weeks Range 12.57 - 23.59 | Updated Date 10/25/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.2 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Nutritional Products | Includes USANA CellSentials and targeted health supplements. | This is the primary revenue engine for the company. |
| Geography (Asia Pacific) | Operations in mainland China and surrounding markets. | This region is the most critical driver of total company sales. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-11-03 | When After Market | Estimate 0.11 | Actual - |
Profitability
Profit Margin -2.43% | Operating Margin (TTM) 4.09% |
Management Effectiveness
Return on Assets (TTM) 3.61% | Return on Equity (TTM) -5.06% |
Valuation
Trailing PE - | Forward PE 8.35 | Enterprise Value 124.33M | Price to Sales(TTM) 0.28 |
Enterprise Value 124.33M | Price to Sales(TTM) 0.28 | ||
Enterprise Value to Revenue 0.14 | Enterprise Value to EBITDA 2.98 | Shares Outstanding 18.48M | Shares Floating 9.93M |
Shares Outstanding 18.48M | Shares Floating 9.93M | ||
Percent Insiders 40.88 | Percent Institutions 62.71 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.